The Charcot-Marie-Tooth Functional Outcome Measure (CMT-FOM).

Overview of attention for article published in Neurology, September 2018

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (93rd percentile)
High Attention Score compared to outputs of the same age and source (82nd percentile)

Mentioned by

news: 3 news outlets
twitter: 1 X user

patent: 1 patent
guideline: 1 clinical guideline source

Readers on

mendeley: 48 Mendeley

So far, Altmetric has seen 3 news stories from 3 outlets.

Applied Therapeutics: Speedy Regulatory Review Of Govorestat Might Be Possible (APLT)

Today Headline, 16 Feb 2024

Applied Therapeutics (NASDAQ:APLT) announced positive 12-month interim results from its phase 3 INSPIRE study using AT-007 for…

Applied Therapeutics: Speedy Regulatory Review Of Govorestat Might Be Possible

Seeking Alpha, 16 Feb 2024

Follow Summary Positive 12-month interim results from the phase 3 INSPIRE study using govorestat for the treatment of patients…

$10M in NINDS Grants Will Support CMT Biomarkers Project at URMC

Medical Health News, 09 Jul 2019

Some $10 million in (NINDS) grants aimed at accelerating clinical trials in rare neurological disorders will support a Charcot-Ma…

This page shows the most recent news stories that mention this research output. Click here to find out how to access more activity.